We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Test Screens for Drug Resistant Bacteria

By LabMedica International staff writers
Posted on 08 Mar 2012
Print article
A laboratory-developed test combining enrichment broth and real-time polymerase chain reaction (rt-PCR) can screen for vancomycin-resistant enterococci (VRE).

The rt-PCR assay, which was developed specifically for the detection of VRE and known as Lab Assay, was evaluated and compared with a commercial VRE detection kit-based method.

Microbiologists at the Karolinska Institute (Stockholm, Sweden) investigated 1,765 fecal or rectal swabs sent to the laboratory for VRE screening in parallel by Lab Assay and the Roche LightCycler VRE kit. Two proven stains of Enterococcus faecium and 52 well-characterized clinical VRE isolates of different clones were tested in the study. Real-time PCR was performed for the detection of VanA and VanB genes.

The diagnostic values for Lab Assay were as follows: 100% sensitivity, 79.92% specificity, 1.94% positive predictive value and 100% negative predictive value, which were comparable to the results from the LightCycler kit-based assay. The detection limit of Lab Assay was 100 to 101 colony-forming units (CFU)/mL of inoculum in broth for both VanA-type and VanB-type VRE. The PCR method developed in the study was approved to be applicable on both the Applied Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) and the LightCycler 480 Real-Time PCR System (Roche Diagnostics GmbH; Mannheim, Germany).

The authors concluded that the flexibility in choosing PCR systems makes it possible that the PCR assay could be fully compatible with the DNA extraction’s platform, providing an integrated workflow. Furthermore, in the material cost around USD 10 per sample is saved when Lab Assay replaces the commercial kit-based method in their routine screening for VRE. Therefore, the laboratory-developed broth-PCR method is an efficient and economical assay for VRE screening. The study was published in March 2012 in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
Karolinska Institute
Applied Biosystems
Roche Diagnostics GmbH

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.